UM
EW icon

UniSuper Management’s Edwards Lifesciences EW Stock Holding History

UniSuper Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.86M Buy
64,797
+11,626
+22% +$974K 0.03% 278
2026
Q1 		$4.26M Sell
53,171
-1,697
-3% -$140K 0.03% 291
2025
Q4 		$4.68M Sell
54,868
-9,163
-14% -$752K 0.03% 272
2025
Q3 		$4.98M Buy
64,031
+14,695
+30% +$1.15M 0.03% 282
2025
Q2 		$3.86M Sell
49,336
-2,709
-5% -$202K 0.03% 296
2025
Q1 		$3.77M Buy
52,045
+1,400
+3% +$100K 0.03% 288
2024
Q4 		$3.75M Sell
50,645
-198,501
-80% -$13.9M 0.03% 281
2024
Q3 		$16.4M Buy
249,146
+209,634
+531% +$15.2M 0.12% 125
2024
Q2 		$3.65M Buy
39,512
+21,442
+119% +$1.9M 0.03% 254
2024
Q1 		$1.73M Sell
18,070
-48,754
-73% -$4.1M 0.02% 285
2023
Q4 		$5.1M Sell
66,824
-3,795
-5% -$264K 0.06% 179
2023
Q3 		$4.89M Sell
70,619
-1,052
-1% -$84.5K 0.06% 176
2023
Q2 		$6.76M Buy
+71,671
New +$6.23M 0.08% 157

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

UniSuper Management's EW Position: Q2 2026 in Review

UniSuper Management increased its Edwards Lifesciences (EW) stake by 22% in Q2 2026, buying an estimated $974K and bringing the position to 64,797 shares worth $5.86M. The position accounts for 0.03% of the portfolio, ranked #278.

UniSuper Management first reported a position in EW in Q2 2023 and has held it in 13 quarters since. The position peaked at $16.4M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • UniSuper Management held 64,797 shares of Edwards Lifesciences worth $5.86M as of Q2 2026.
  • UniSuper Management bought 11,626 Edwards Lifesciences shares in Q2 2026, an estimated $974K.
  • Edwards Lifesciences made up 0.03% of UniSuper Management's portfolio in Q2 2026, its #278 holding.
  • UniSuper Management first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Edwards Lifesciences position peaked at $16.4M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.